About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Chemotherapy Market Size, Regional Analysis, Report to 2031
Chemotherapy Market

Chemotherapy Market Size, Share & Trends Analysis Report By Drugs (Alkylating Agents, Antimetabolites, Anti-Tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Others), By Indication (Leukemia, Lymphoma, Breast Cancer, Ovarian Cancer, Lung Cancer, Myeloma, Sarcoma, Others), By Route of Drugs (Oral, Intravenous), By End User (Hospitals, Research Institutes, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRHI69DR
Last Updated : Aug 12, 2024
Author : Straits Research
Starting From
USD 1850
Buy Now
File Formats

Market Segmentation

  1. Chemotherapy Market, By Drugs (2021-2031)
    1. Alkylating Agents
    2. Antimetabolites
    3. Anti-Tumor Antibiotics
    4. Topoisomerase Inhibitors
    5. Mitotic Inhibitors
    6. Others
  2. Chemotherapy Market, By Indication (2021-2031)
    1. Leukemia
    2. Lymphoma
    3. Breast Cancer
    4. Ovarian Cancer
    5. Lung Cancer
    6. Myeloma
    7. Sarcoma
    8. Others
  3. Chemotherapy Market, By Route of Drugs (2021-2031)
    1. Oral
    2. Intravenous
  4. Chemotherapy Market, By End User (2021-2031)
    1. Hospitals
    2. Research Institutes
    3. Others
    1. North America
      1. North America Chemotherapy Market, By Drugs
        1. Alkylating Agents
          1. Antimetabolites
            1. Anti-Tumor Antibiotics
              1. Topoisomerase Inhibitors
                1. Mitotic Inhibitors
                  1. Others
                  2. North America Chemotherapy Market, By Indication
                    1. Leukemia
                      1. Lymphoma
                        1. Breast Cancer
                          1. Ovarian Cancer
                            1. Lung Cancer
                              1. Myeloma
                                1. Sarcoma
                                  1. Others
                                  2. North America Chemotherapy Market, By Route of Drugs
                                    1. Oral
                                      1. Intravenous
                                      2. North America Chemotherapy Market, By End User
                                        1. Hospitals
                                          1. Research Institutes
                                            1. Others
                                            2. U.S.
                                              1. U.S. Chemotherapy Market, By Drugs
                                                1. Alkylating Agents
                                                  1. Antimetabolites
                                                    1. Anti-Tumor Antibiotics
                                                      1. Topoisomerase Inhibitors
                                                        1. Mitotic Inhibitors
                                                          1. Others
                                                          2. U.S. Chemotherapy Market, By Indication
                                                            1. Leukemia
                                                              1. Lymphoma
                                                                1. Breast Cancer
                                                                  1. Ovarian Cancer
                                                                    1. Lung Cancer
                                                                      1. Myeloma
                                                                        1. Sarcoma
                                                                          1. Others
                                                                          2. U.S. Chemotherapy Market, By Route of Drugs
                                                                            1. Oral
                                                                              1. Intravenous
                                                                              2. U.S. Chemotherapy Market, By End User
                                                                                1. Hospitals
                                                                                  1. Research Institutes
                                                                                    1. Others
                                                                                  2. Canada
                                                                                2. Europe
                                                                                  1. Europe Chemotherapy Market, By Drugs
                                                                                    1. Alkylating Agents
                                                                                      1. Antimetabolites
                                                                                        1. Anti-Tumor Antibiotics
                                                                                          1. Topoisomerase Inhibitors
                                                                                            1. Mitotic Inhibitors
                                                                                              1. Others
                                                                                              2. Europe Chemotherapy Market, By Indication
                                                                                                1. Leukemia
                                                                                                  1. Lymphoma
                                                                                                    1. Breast Cancer
                                                                                                      1. Ovarian Cancer
                                                                                                        1. Lung Cancer
                                                                                                          1. Myeloma
                                                                                                            1. Sarcoma
                                                                                                              1. Others
                                                                                                              2. Europe Chemotherapy Market, By Route of Drugs
                                                                                                                1. Oral
                                                                                                                  1. Intravenous
                                                                                                                  2. Europe Chemotherapy Market, By End User
                                                                                                                    1. Hospitals
                                                                                                                      1. Research Institutes
                                                                                                                        1. Others
                                                                                                                        2. U.K.
                                                                                                                          1. U.K. Chemotherapy Market, By Drugs
                                                                                                                            1. Alkylating Agents
                                                                                                                              1. Antimetabolites
                                                                                                                                1. Anti-Tumor Antibiotics
                                                                                                                                  1. Topoisomerase Inhibitors
                                                                                                                                    1. Mitotic Inhibitors
                                                                                                                                      1. Others
                                                                                                                                      2. U.K. Chemotherapy Market, By Indication
                                                                                                                                        1. Leukemia
                                                                                                                                          1. Lymphoma
                                                                                                                                            1. Breast Cancer
                                                                                                                                              1. Ovarian Cancer
                                                                                                                                                1. Lung Cancer
                                                                                                                                                  1. Myeloma
                                                                                                                                                    1. Sarcoma
                                                                                                                                                      1. Others
                                                                                                                                                      2. U.K. Chemotherapy Market, By Route of Drugs
                                                                                                                                                        1. Oral
                                                                                                                                                          1. Intravenous
                                                                                                                                                          2. U.K. Chemotherapy Market, By End User
                                                                                                                                                            1. Hospitals
                                                                                                                                                              1. Research Institutes
                                                                                                                                                                1. Others
                                                                                                                                                              2. Germany
                                                                                                                                                              3. France
                                                                                                                                                              4. Spain
                                                                                                                                                              5. Italy
                                                                                                                                                              6. Russia
                                                                                                                                                              7. Nordic
                                                                                                                                                              8. Benelux
                                                                                                                                                              9. Rest of Europe
                                                                                                                                                            2. APAC
                                                                                                                                                              1. APAC Chemotherapy Market, By Drugs
                                                                                                                                                                1. Alkylating Agents
                                                                                                                                                                  1. Antimetabolites
                                                                                                                                                                    1. Anti-Tumor Antibiotics
                                                                                                                                                                      1. Topoisomerase Inhibitors
                                                                                                                                                                        1. Mitotic Inhibitors
                                                                                                                                                                          1. Others
                                                                                                                                                                          2. APAC Chemotherapy Market, By Indication
                                                                                                                                                                            1. Leukemia
                                                                                                                                                                              1. Lymphoma
                                                                                                                                                                                1. Breast Cancer
                                                                                                                                                                                  1. Ovarian Cancer
                                                                                                                                                                                    1. Lung Cancer
                                                                                                                                                                                      1. Myeloma
                                                                                                                                                                                        1. Sarcoma
                                                                                                                                                                                          1. Others
                                                                                                                                                                                          2. APAC Chemotherapy Market, By Route of Drugs
                                                                                                                                                                                            1. Oral
                                                                                                                                                                                              1. Intravenous
                                                                                                                                                                                              2. APAC Chemotherapy Market, By End User
                                                                                                                                                                                                1. Hospitals
                                                                                                                                                                                                  1. Research Institutes
                                                                                                                                                                                                    1. Others
                                                                                                                                                                                                    2. China
                                                                                                                                                                                                      1. China Chemotherapy Market, By Drugs
                                                                                                                                                                                                        1. Alkylating Agents
                                                                                                                                                                                                          1. Antimetabolites
                                                                                                                                                                                                            1. Anti-Tumor Antibiotics
                                                                                                                                                                                                              1. Topoisomerase Inhibitors
                                                                                                                                                                                                                1. Mitotic Inhibitors
                                                                                                                                                                                                                  1. Others
                                                                                                                                                                                                                  2. China Chemotherapy Market, By Indication
                                                                                                                                                                                                                    1. Leukemia
                                                                                                                                                                                                                      1. Lymphoma
                                                                                                                                                                                                                        1. Breast Cancer
                                                                                                                                                                                                                          1. Ovarian Cancer
                                                                                                                                                                                                                            1. Lung Cancer
                                                                                                                                                                                                                              1. Myeloma
                                                                                                                                                                                                                                1. Sarcoma
                                                                                                                                                                                                                                  1. Others
                                                                                                                                                                                                                                  2. China Chemotherapy Market, By Route of Drugs
                                                                                                                                                                                                                                    1. Oral
                                                                                                                                                                                                                                      1. Intravenous
                                                                                                                                                                                                                                      2. China Chemotherapy Market, By End User
                                                                                                                                                                                                                                        1. Hospitals
                                                                                                                                                                                                                                          1. Research Institutes
                                                                                                                                                                                                                                            1. Others
                                                                                                                                                                                                                                          2. Korea
                                                                                                                                                                                                                                          3. Japan
                                                                                                                                                                                                                                          4. India
                                                                                                                                                                                                                                          5. Australia
                                                                                                                                                                                                                                          6. Taiwan
                                                                                                                                                                                                                                          7. South East Asia
                                                                                                                                                                                                                                          8. Rest of Asia-Pacific
                                                                                                                                                                                                                                        2. Middle East and Africa
                                                                                                                                                                                                                                          1. Middle East and Africa Chemotherapy Market, By Drugs
                                                                                                                                                                                                                                            1. Alkylating Agents
                                                                                                                                                                                                                                              1. Antimetabolites
                                                                                                                                                                                                                                                1. Anti-Tumor Antibiotics
                                                                                                                                                                                                                                                  1. Topoisomerase Inhibitors
                                                                                                                                                                                                                                                    1. Mitotic Inhibitors
                                                                                                                                                                                                                                                      1. Others
                                                                                                                                                                                                                                                      2. Middle East and Africa Chemotherapy Market, By Indication
                                                                                                                                                                                                                                                        1. Leukemia
                                                                                                                                                                                                                                                          1. Lymphoma
                                                                                                                                                                                                                                                            1. Breast Cancer
                                                                                                                                                                                                                                                              1. Ovarian Cancer
                                                                                                                                                                                                                                                                1. Lung Cancer
                                                                                                                                                                                                                                                                  1. Myeloma
                                                                                                                                                                                                                                                                    1. Sarcoma
                                                                                                                                                                                                                                                                      1. Others
                                                                                                                                                                                                                                                                      2. Middle East and Africa Chemotherapy Market, By Route of Drugs
                                                                                                                                                                                                                                                                        1. Oral
                                                                                                                                                                                                                                                                          1. Intravenous
                                                                                                                                                                                                                                                                          2. Middle East and Africa Chemotherapy Market, By End User
                                                                                                                                                                                                                                                                            1. Hospitals
                                                                                                                                                                                                                                                                              1. Research Institutes
                                                                                                                                                                                                                                                                                1. Others
                                                                                                                                                                                                                                                                                2. UAE
                                                                                                                                                                                                                                                                                  1. UAE Chemotherapy Market, By Drugs
                                                                                                                                                                                                                                                                                    1. Alkylating Agents
                                                                                                                                                                                                                                                                                      1. Antimetabolites
                                                                                                                                                                                                                                                                                        1. Anti-Tumor Antibiotics
                                                                                                                                                                                                                                                                                          1. Topoisomerase Inhibitors
                                                                                                                                                                                                                                                                                            1. Mitotic Inhibitors
                                                                                                                                                                                                                                                                                              1. Others
                                                                                                                                                                                                                                                                                              2. UAE Chemotherapy Market, By Indication
                                                                                                                                                                                                                                                                                                1. Leukemia
                                                                                                                                                                                                                                                                                                  1. Lymphoma
                                                                                                                                                                                                                                                                                                    1. Breast Cancer
                                                                                                                                                                                                                                                                                                      1. Ovarian Cancer
                                                                                                                                                                                                                                                                                                        1. Lung Cancer
                                                                                                                                                                                                                                                                                                          1. Myeloma
                                                                                                                                                                                                                                                                                                            1. Sarcoma
                                                                                                                                                                                                                                                                                                              1. Others
                                                                                                                                                                                                                                                                                                              2. UAE Chemotherapy Market, By Route of Drugs
                                                                                                                                                                                                                                                                                                                1. Oral
                                                                                                                                                                                                                                                                                                                  1. Intravenous
                                                                                                                                                                                                                                                                                                                  2. UAE Chemotherapy Market, By End User
                                                                                                                                                                                                                                                                                                                    1. Hospitals
                                                                                                                                                                                                                                                                                                                      1. Research Institutes
                                                                                                                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                                                                                                                      2. Turkey
                                                                                                                                                                                                                                                                                                                      3. Saudi Arabia
                                                                                                                                                                                                                                                                                                                      4. South Africa
                                                                                                                                                                                                                                                                                                                      5. Egypt
                                                                                                                                                                                                                                                                                                                      6. Nigeria
                                                                                                                                                                                                                                                                                                                      7. Rest of MEA
                                                                                                                                                                                                                                                                                                                    2. LATAM
                                                                                                                                                                                                                                                                                                                      1. LATAM Chemotherapy Market, By Drugs
                                                                                                                                                                                                                                                                                                                        1. Alkylating Agents
                                                                                                                                                                                                                                                                                                                          1. Antimetabolites
                                                                                                                                                                                                                                                                                                                            1. Anti-Tumor Antibiotics
                                                                                                                                                                                                                                                                                                                              1. Topoisomerase Inhibitors
                                                                                                                                                                                                                                                                                                                                1. Mitotic Inhibitors
                                                                                                                                                                                                                                                                                                                                  1. Others
                                                                                                                                                                                                                                                                                                                                  2. LATAM Chemotherapy Market, By Indication
                                                                                                                                                                                                                                                                                                                                    1. Leukemia
                                                                                                                                                                                                                                                                                                                                      1. Lymphoma
                                                                                                                                                                                                                                                                                                                                        1. Breast Cancer
                                                                                                                                                                                                                                                                                                                                          1. Ovarian Cancer
                                                                                                                                                                                                                                                                                                                                            1. Lung Cancer
                                                                                                                                                                                                                                                                                                                                              1. Myeloma
                                                                                                                                                                                                                                                                                                                                                1. Sarcoma
                                                                                                                                                                                                                                                                                                                                                  1. Others
                                                                                                                                                                                                                                                                                                                                                  2. LATAM Chemotherapy Market, By Route of Drugs
                                                                                                                                                                                                                                                                                                                                                    1. Oral
                                                                                                                                                                                                                                                                                                                                                      1. Intravenous
                                                                                                                                                                                                                                                                                                                                                      2. LATAM Chemotherapy Market, By End User
                                                                                                                                                                                                                                                                                                                                                        1. Hospitals
                                                                                                                                                                                                                                                                                                                                                          1. Research Institutes
                                                                                                                                                                                                                                                                                                                                                            1. Others
                                                                                                                                                                                                                                                                                                                                                            2. Brazil
                                                                                                                                                                                                                                                                                                                                                              1. Brazil Chemotherapy Market, By Drugs
                                                                                                                                                                                                                                                                                                                                                                1. Alkylating Agents
                                                                                                                                                                                                                                                                                                                                                                  1. Antimetabolites
                                                                                                                                                                                                                                                                                                                                                                    1. Anti-Tumor Antibiotics
                                                                                                                                                                                                                                                                                                                                                                      1. Topoisomerase Inhibitors
                                                                                                                                                                                                                                                                                                                                                                        1. Mitotic Inhibitors
                                                                                                                                                                                                                                                                                                                                                                          1. Others
                                                                                                                                                                                                                                                                                                                                                                          2. Brazil Chemotherapy Market, By Indication
                                                                                                                                                                                                                                                                                                                                                                            1. Leukemia
                                                                                                                                                                                                                                                                                                                                                                              1. Lymphoma
                                                                                                                                                                                                                                                                                                                                                                                1. Breast Cancer
                                                                                                                                                                                                                                                                                                                                                                                  1. Ovarian Cancer
                                                                                                                                                                                                                                                                                                                                                                                    1. Lung Cancer
                                                                                                                                                                                                                                                                                                                                                                                      1. Myeloma
                                                                                                                                                                                                                                                                                                                                                                                        1. Sarcoma
                                                                                                                                                                                                                                                                                                                                                                                          1. Others
                                                                                                                                                                                                                                                                                                                                                                                          2. Brazil Chemotherapy Market, By Route of Drugs
                                                                                                                                                                                                                                                                                                                                                                                            1. Oral
                                                                                                                                                                                                                                                                                                                                                                                              1. Intravenous
                                                                                                                                                                                                                                                                                                                                                                                              2. Brazil Chemotherapy Market, By End User
                                                                                                                                                                                                                                                                                                                                                                                                1. Hospitals
                                                                                                                                                                                                                                                                                                                                                                                                  1. Research Institutes
                                                                                                                                                                                                                                                                                                                                                                                                    1. Others
                                                                                                                                                                                                                                                                                                                                                                                                  2. Mexico
                                                                                                                                                                                                                                                                                                                                                                                                  3. Argentina
                                                                                                                                                                                                                                                                                                                                                                                                  4. Chile
                                                                                                                                                                                                                                                                                                                                                                                                  5. Colombia
                                                                                                                                                                                                                                                                                                                                                                                                  6. Rest of LATAM

                                                                                                                                                                                                                                                                                                                                                                                              Related Reports

                                                                                                                                                                                                                                                                                                                                                                                              Global Report
                                                                                                                                                                                                                                                                                                                                                                                              The global cryotherapy market size was valued at USD 6.36 billion in 2021 and is projected to reach USD 11.85 billion by 2030, registering a CAGR of 7.16% from 2022 to 2030. Cryotherapy, also known as cold treatment or icepack therapy, is used to de
                                                                                                                                                                                                                                                                                                                                                                                              Buy Now
                                                                                                                                                                                                                                                                                                                                                                                              Global Report
                                                                                                                                                                                                                                                                                                                                                                                              Electrotherapy Market Size The global electrotherapy market size was valued at USD 1265.85 million in 2024 and is projected to reach from USD 1331.67 million in 2025 to USD 1997.67 million by 2033, growing at a CAGR of 5.20% during the forecast peri
                                                                                                                                                                                                                                                                                                                                                                                              Buy Now
                                                                                                                                                                                                                                                                                                                                                                                              Global Report
                                                                                                                                                                                                                                                                                                                                                                                              The global phototherapy market size was valued at USD 581.50 million in 2022. It is projected to reach USD 886.75 million by 2031, growing at a CAGR of 4.80% during the forecast period (2023-2031).  Highlights The conventional phototherapy e
                                                                                                                                                                                                                                                                                                                                                                                              Buy Now

                                                                                                                                                                                                                                                                                                                                                                                              Purchase Benefits

                                                                                                                                                                                                                                                                                                                                                                                              • Eligible for a free updated report next year
                                                                                                                                                                                                                                                                                                                                                                                              • Completely customizable scope
                                                                                                                                                                                                                                                                                                                                                                                              • 30% discount on your next purchase
                                                                                                                                                                                                                                                                                                                                                                                              • Dedicated account manager
                                                                                                                                                                                                                                                                                                                                                                                              • Query resolution within 24 hours
                                                                                                                                                                                                                                                                                                                                                                                              • Permission to print the report

                                                                                                                                                                                                                                                                                                                                                                                              We are featured on :

                                                                                                                                                                                                                                                                                                                                                                                              www.straitsresearch.com
                                                                                                                                                                                                                                                                                                                                                                                              © Copyright . All rights Reserved.